Outlook Therapeutics, Inc. · NASDAQ:OTLK
Hilzinger Kurt J bought 400,000 Outlook Therapeutics, Inc. shares (Form 4)
Traded May 26, 2026 · Filed May 27, 2026
On May 26, 2026, Hilzinger Kurt J (Director) bought 400,000 Outlook Therapeutics, Inc. shares at US$0.44 for US$176K, leaving 423,655 shares. Filed May 27, 2026 (Form 4).
- Bought
- 400,000 shares
- Price
- US$0.44
- Value
- US$176K
- Holding after
- 423,655 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 26, 2026 | Common Stock | Buy | 400,000 | US$0.44 | 423,655 | Direct |
Source
Related
- Outlook Therapeutics, Inc.
- Hilzinger Kurt J
- Outlook Therapeutics, Inc. shareholders
- Schedule 13G · Empery Asset Management, LP · Oct 13, 2026
- Schedule 13G · CVI Investments, Inc. · Aug 19, 2026
- Form 4 · Jahr Robert Charles · Aug 14, 2026
- Form 4 · Kenyon Lawrence A · Aug 14, 2026
- Form 4 · Sukhtian Ghiath M. · Aug 14, 2026